Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial

OBJECTIVESThe study sought to evaluate the impact of diabetes mellitus on 3-year clinical outcome in patients undergoing drug-coated balloon (DCB) or drug-eluting stent (DES) treatment for de novo lesions. BACKGROUNDFor treatment of de novo coronary small vessel disease, DCBs are noninferior to DES....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JACC. Cardiovascular interventions 2021-08, Vol.14 (16), p.1789-1798
Hauptverfasser: Wöhrle, Jochen, Scheller, Bruno, Seeger, Julia, Farah, Ahmed, Ohlow, Marc-Alexander, Mangner, Norman, Möbius-Winkler, Sven, Weilenmann, Daniel, Stachel, Georg, Leibundgut, Gregor, Rickenbacher, Peter, Cattaneo, Marco, Gilgen, Nicole, Kaiser, Christoph, Jeger, Raban V
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:OBJECTIVESThe study sought to evaluate the impact of diabetes mellitus on 3-year clinical outcome in patients undergoing drug-coated balloon (DCB) or drug-eluting stent (DES) treatment for de novo lesions. BACKGROUNDFor treatment of de novo coronary small vessel disease, DCBs are noninferior to DES. METHODSIn this prespecified analysis of a multicenter, randomized, noninferiority trial, including 758 patients with de novo lesions in coronary vessels
ISSN:1876-7605
DOI:10.1016/j.jcin.2021.06.025